Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
123,650,000
-
Total 13F shares
-
123,583,310
-
Share change
-
-918,262
-
Total reported value
-
$5,026,636,534
-
Put/Call ratio
-
65%
-
Price per share
-
$40.68
-
Number of holders
-
409
-
Value change
-
-$29,500,183
-
Number of buys
-
209
-
Number of sells
-
192
Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q1 2024
As of 31 Mar 2024,
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by
409 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
123,583,310 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, SNYDER CAPITAL MANAGEMENT L P, Artisan Partners Limited Partnership, ALLIANCEBERNSTEIN L.P., JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, MACQUARIE GROUP LTD, and TD Asset Management Inc.
This page lists
409
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.